Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.

D B Clifford1, C Yiannoutsos, M Glicksman

  • 1Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA. cliffordd@neuro.wustl.edu

Neurology
|February 20, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials.

The journal of prevention of Alzheimer's disease..·2024
Same author

Gaussian Processes for Hearing Threshold Estimation Using Auditory Brainstem Responses.

IEEE transactions on bio-medical engineering·2023
Same author

The East Africa Consortium for human papillomavirus and cervical cancer in women living with HIV/AIDS.

Annals of medicine·2022
Same author

Controlling test specificity for auditory evoked response detection using a frequency domain bootstrap.

Journal of neuroscience methods·2021
Same author

Checkpoint therapy for progressive multifocal leukoencephalopathy: pointless?

European journal of neurology·2020
Same author

A group sequential test for ABR detection.

International journal of audiology·2019

Highly active antiretroviral therapy (HAART) has improved outcomes for patients with human immunodeficiency virus (HIV) and progressive multifocal leukoencephalopathy (PML). This HIV treatment led to longer survival for PML patients, correlating with reduced viral load.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a serious opportunistic infection in human immunodeficiency virus (HIV) patients.
  • The advent of highly active antiretroviral therapy (HAART) has altered the natural history of many HIV-related complications.

Purpose of the Study:

  • To evaluate the impact of HAART on the prognosis of HIV-associated PML.
  • To assess survival rates and their correlation with viral load in PML patients receiving HAART.

Main Methods:

  • A cohort of 25 HIV-infected patients diagnosed with PML was retrospectively analyzed.
  • Survival data and HIV RNA viral load measurements were collected and analyzed.

Main Results:

Related Experiment Videos

  • Patients treated with HAART demonstrated a median survival exceeding 46 weeks.
  • This survival rate represents a significant improvement compared to historical data.
  • Survival duration correlated positively with reductions in HIV RNA viral load.

Conclusions:

  • Current antiretroviral therapy regimens are crucial for improving the outlook of PML in the context of HIV infection.
  • HAART offers a more favorable prognosis for HIV patients with PML.